Deschloroclozapine

CAS No. 1977-07-7

Deschloroclozapine( —— )

Catalog No. M26171 CAS No. 1977-07-7

Deschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 63 In Stock
5MG 45 In Stock
10MG 72 In Stock
25MG 140 In Stock
50MG 260 In Stock
100MG 404 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Deschloroclozapine
  • Note
    Research use only, not for human use.
  • Brief Description
    Deschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist.
  • Description
    Deschloroclozapine, a metabolite of Clozapine, is a highly potent muscarinic DREADDs agonist. Deschloroclozapine binds to DREADD receptor subtypes hM3Dq and hM4Di with Ki of 6.3 and 4.2 nM, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GABAA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1977-07-7
  • Formula Weight
    292.386
  • Molecular Formula
    C18H20N4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (342.02 mM)
  • SMILES
    CN1CCN(CC1)C1=Nc2ccccc2Nc2ccccc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ali Y Benkherouf, et al. Hops Compounds Modulatory Effects and 6-prenylnaringenin Dual Mode of Action on GABA AReceptors. Eur J Pharmacol. 2020 Apr 15;873:172962.
molnova catalog
related products
  • Tolimidone

    MLR-1023 is a chemical compound which inhibits acid secretion in animal models and also acts as a bronchodilator in histamine-challenged animals.

  • Triplin

    Triplin is a chelator of copper ion. Triplin affects the transport of copper ions from ATX1 to RAN1.

  • Cdk4/6 Inhibitor IV

    Cdk4/6 inhibitor IV is a cell-permeable triaminopyrimidine that reversibly blocks Cdk4/cyclin D1 and Cdk6/cyclin D1 activity with IC50 values of 1.5 and 5.6 μM, respectively.